Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation

被引：0
|
作者：
Woolacott, N. [1 ]
Vergel, Y. Bravo
Hawkins, N.
Kainth, A.
Khadjesari, Z.
Misso, K.
Light, K.
Asseburg, C.
Palmer, S.
Claxton, K.
Bruce, I.
Sculpher, M.
Riemsma, R.
机构：
[1] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England
[2] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[3] Univ Manchester, ARC Epidemiol Unit, Manchester M13 9PL, Lancs, England
来源：
HEALTH TECHNOLOGY ASSESSMENT | 2006年 / 10卷 / 31期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1 / +
页数：230
相关论文
共 50 条
  • [1] Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
    Rodgers, M.
    Epstein, D.
    Bojke, L.
    Yang, H.
    Craig, D.
    Fonseca, T.
    Myers, L.
    Bruce, I.
    Chalmers, R.
    Bujkiewicz, S.
    Lai, M.
    Cooper, N.
    Abrams, K.
    Spiegelhalter, D.
    Sutton, A.
    Sculpher, M.
    Woolacott, N.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (10) : 1 - +
  • [2] Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review
    Woolacott, N. F.
    Khadjesari, Z. C. S.
    Bruce, I. N.
    Riemsma, R. P.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : 587 - 593
  • [3] Economic evaluation of infliximab and etanercept: A systematic review
    Lopez-Olivo, M.
    Moffett, M. M.
    Kallen, M. A.
    Ortiz, Z.
    Skidmore, B.
    Suarez-Almazor, M. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 329 - 330
  • [4] Economic evaluation of infliximab and etanercept: A systematic review.
    Lopez-Olivo, Maria A.
    Moffett, Maurice L.
    Kallen, Michael A.
    Ortiz, Zulma
    Skidmore, Becky
    Suarez-Almazor, Maria E.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S336 - S336
  • [5] Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation
    McLeod, C.
    Bagust, A.
    Boland, A.
    Dagenais, P.
    Dickson, R.
    Dundar, Y.
    Hill, R. A.
    Jones, A.
    Mota, R. Mujica
    Walley, T.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (28) : IX - +
  • [6] A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Chen, Y-F
    Jobanputra, P.
    Barton, P.
    Jowett, S.
    Bryan, S.
    Clark, W.
    Fry-Smith, A.
    Burls, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) : 1 - +
  • [7] ECONOMIC EVALUATIONS OF ETANERCEPT IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS IN SPAIN: A SYSTEMATIC REVIEW
    Peral, C.
    Gomez, I
    Burgos, R.
    Rebollo, F.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A530 - A530
  • [8] Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
    Lluís Puig
    Lourdes Rodríguez Fernández-Freire
    Ramón Burgos-Pol
    Ismael Gomez
    Carmen Peral
    Susana Gomez
    Francisco José Rebollo Laserna
    [J]. Dermatology and Therapy, 2019, 9 : 479 - 496
  • [9] Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
    Puig, Lluis
    Rodriguez Fernandez-Freire, Lourdes
    Burgos-Pol, Ramon
    Gomez, Ismael
    Peral, Carmen
    Gomez, Susana
    Rebollo Laserna, Francisco Jose
    [J]. DERMATOLOGY AND THERAPY, 2019, 9 (03) : 479 - 496
  • [10] A cost-efficacy analysis of etanercept and infliximab in the treatment of psoriatic arthritis
    Yu, EB
    Woolley, JM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 400 - 400
12345